← Leaderboards
Thomas Hudson Sanderson
Wayne State University
$4,264,130
Attributed
$9,223,358
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,223,358 · 5
By mechanism
R01$5,318,048 · 3
U44$2,085,293 · 1
R42$1,820,017 · 1
Top collaborators
- Maik Huettemann16 shared
- Rita Kumar5 shared
- Wiley Thomas Waddell3 shared
Most similar at Wayne State University
Same institution · by research overlap
- Maik Huettemann$6,887,189
- Sidhartha Tan$11,899,699
- Jeannette M Vasquez Vivar$5,991,870
- Ivan Avrutsky$409,405
- Paul R Van Tassel$1,001,149
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaReperfusion TherapyBrainReperfusion InjuryBlood FlowBrain IschemiaMediatingDisabilityIschemiaMolecularCerebrumPreventFree RadicalsOxidasesLightNeuroprotectionProductionCytochrome C OxidaseCause Of DeathBrain InjuriesOxygenGenerationsReactive Oxygen SpeciesPhototherapy
Grant awards (21)
Non-invasive mitochondrial modulation therapy for ischemic stroke$414,352
R01 · FY2025 · NS · contact PI
Non-invasive mitochondrial modulation therapy for ischemic stroke$446,582
R01 · FY2024 · NS · contact PI
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$99,400
U44 · FY2024 · NS
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$986,555
U44 · FY2023 · NS
Non-invasive mitochondrial modulation therapy for ischemic stroke$473,183
R01 · FY2023 · NS · contact PI
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$999,338
U44 · FY2022 · NS
Non-invasive mitochondrial modulation therapy for ischemic stroke$485,970
R01 · FY2022 · NS · contact PI
Non-invasive mitochondrial modulation therapy for ischemic stroke$491,547
R01 · FY2021 · NS · contact PI
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$768,981
R42 · FY2020 · NS · contact PI
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$802,994
R42 · FY2019 · NS · contact PI
Limiting brain reperfusion injury by controlling mitochondrial function$339,077
R01 · FY2018 · NS · contact PI
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$248,042
R42 · FY2018 · NS · contact PI
Mitochondrial Integrity Regulates Cerebral Reperfusion Injury$332,500
R01 · FY2017 · NS
Limiting brain reperfusion injury by controlling mitochondrial function$200,883
R01 · FY2017 · NS · contact PI
Limiting brain reperfusion injury by controlling mitochondrial function$135,992
R01 · FY2017 · NS · contact PI
Limiting brain reperfusion injury by controlling mitochondrial function$336,692
R01 · FY2016 · NS
Mitochondrial Integrity Regulates Cerebral Reperfusion Injury$332,500
R01 · FY2016 · NS
Limiting brain reperfusion injury by controlling mitochondrial function$334,596
R01 · FY2015 · NS
Mitochondrial Integrity Regulates Cerebral Reperfusion Injury$332,500
R01 · FY2015 · NS
Mitochondrial Integrity Regulates Cerebral Reperfusion Injury$329,174
R01 · FY2014 · NS
Mitochondrial Integrity Regulates Cerebral Reperfusion Injury$332,500
R01 · FY2013 · NS